Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Other financing activities (2021 - 2023)

Werewolf Therapeutics (HOWL) has disclosed Other financing activities for 3 consecutive years, with -$90000.0 as the latest value for Q2 2023.

  • Quarterly Other financing activities fell 137.66% to -$90000.0 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was -$90000.0 through Sep 2024, down 188.24% year-over-year, with the annual reading at $673000.0 for FY2024, N/A changed from the prior year.
  • Other financing activities for Q2 2023 was -$90000.0 at Werewolf Therapeutics, down from $90000.0 in the prior quarter.
  • The five-year high for Other financing activities was $1.5 million in Q2 2021, with the low at -$90000.0 in Q2 2023.
  • Average Other financing activities over 3 years is $378875.0, with a median of $269500.0 recorded in 2021.
  • The sharpest move saw Other financing activities crashed 66.34% in 2022, then plummeted 137.66% in 2023.
  • Over 3 years, Other financing activities stood at $300000.0 in 2021, then plummeted by 66.0% to $102000.0 in 2022, then tumbled by 188.24% to -$90000.0 in 2023.
  • According to Business Quant data, Other financing activities over the past three periods came in at -$90000.0, $90000.0, and $102000.0 for Q2 2023, Q1 2023, and Q3 2022 respectively.